Pharmaceutical News
The US Department of Health and Human Services (HHS)—through the Centers for Medicare and Medicaid Services (CMS)—has announced that some Medicare enrollees will pay less for 64 drugs available through Medicare Part B. 27 June 2024
The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have issued recommendations to tackle shortages of glucagon-like peptide-1 (GLP-1) receptor agonists. 26 June 2024
In a filing with the US Securities and Exchange Commission (SEC), Californian biotech Alumis has revealed it aims to raise around $300 million in its upcoming initial public offering (IPO). 25 June 2024
Exclusive
Company Spotlight
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.
In Brief
Amendments to the Therapeutic Goods Regulations 1990 (Schedule 5, item 6 have been made .... 24 June 2024
Mergers and Acquisitions
CASI Pharmaceuticals (Nasdaq: CASI) has announced a preliminary proposal from its chairman and chief executive, Wei-Wu He, to acquire the company's business operations in China. 27 June 2024
21 June 2024
20 June 2024
6 June 2024
6 June 2024
Editor's Pick
Boardroom
Sanofi appoints Audrey Duval Derveloy as global head of corporate affairs 21 June 2024
Munich-based radiopharmaceutical company ITM Isotope Technologies has appointed Andrew Cavey as its new chief executive officer. 20 June 2024
In a post on LinkedIn, Bayer (BAYN: DE) senior VP and biotech head Jens Vogel has announced his intention to step down. 12 June 2024
Michaela Eikermann returns to Germany’s IQWiG as deputy director 10 June 2024
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze